Prophylaxis

Displaying 1 - 10 of 34

Game development prevents cognitive decline in the elderly

Game development prevents cognitive decline in the elderly
Information technology can be a powerful tool for preserving the cognitive functions of people over 60 years of age. This proposition was the basis of Fabio Ota’s initiative, which was undertaken in a research project supported by FAPESP’s Innovative Research in Small Business (PIPE) to test the benefits of teaching game programming techniques to a group of 46 people over the age of sixty, with the aim of developing logical reasoning and preventing cognitive decline.
9th August 2017

Optimising immunisation with T cell receptors

Optimising immunisation with T cell receptors
When T cells encounter an antigen, they proliferate and produce various types of daughter cells. A team at the Technical University of Munich (TUM) has now refuted the prevailing hypothesis that this immune response is largely predetermined by the individual structure of the T cell receptor. Instead, the influence of the T cell receptor can be described only in probabilistic terms. Such mathematical models may help to improve the design of future vaccination strategies.
1st August 2017

Microneedle patch improves efficacy of seasonal flu vaccines

Microneedle patch improves efficacy of seasonal flu vaccines
A boosting skin vaccination with a biodegradable microneedle patch and protein constructed from sequences of influenza virus subtypes could improve the effectiveness of conventional influenza vaccines, according to a study led by Georgia State University. To increase the protection offered by standard influenza vaccines, Dr. Baozhong Wang’s group made a fusion protein (4M2e-tFliC) with four different sequences of M2e from four different influenza subtypes.
24th July 2017


Mosquito net thwarts mosquitoes resistant to insecticides

Mosquito net thwarts mosquitoes resistant to insecticides
BASF has received a recommendation from the World Health Organisation (WHO) for Interceptor G2, a long-lasting insecticide-treated mosquito net (LN) based on chlorfenapyr. Chlorfenapyr is a completely new insecticide class for combating mosquitoes for public health. This is the first WHO recommendation for a product based on a new insecticide class in more than 30 years.
14th July 2017

Ergonomic mouse aims to relieve users from strain

Ergonomic mouse aims to relieve users from strain
Using computer mice more than 20 hours per week is associated with carpal tunnel syndrome. Classic computer mice force users into a pronated forearm position, placing stress on the nerves of the carpal tunnel. The PenClic R2 is an unconventional mouse that aims to relieve users from such strain by putting their hands into a more neutral position. The Penclic R2 looks like a regular mouse with a pen attached to it.
11th July 2017

Biomedical startup obtains CE mark for blood analysis platform

Biomedical startup obtains CE mark for blood analysis platform
Finnish biomedical startup Nightingale Health has announced CE marking for its blood biomarker analysis platform. The CE mark enables the clinical use of the analysis service and the analysed measures of creatinine and glucose in the EU region. Nightingale’s goal is to bring dozens of biomarkers included in the analysis platform gradually available for clinical use within the next year. The obtained CE mark is a step towards the company’s aim, enabling better prediction and targeted care for chronic diseases.
5th July 2017

Preparing the EU for the next pandemic

Preparing the EU for the next pandemic
  For 18 months, the PANDEM project has been preparing recommendations to help the EU face a potential pandemic. Armed with its planning tool and other project outcomes, the team has identified research priorities and innovations needed to strengthen preparedness for pandemics.
28th June 2017

Uncovering the best delivery mode for potential HIV vaccine

Uncovering the best delivery mode for potential HIV vaccine
For decades, HIV has successfully evaded all efforts to create an effective vaccine but researchers at The Scripps Research Institute (TSRI) and the La Jolla Institute for Allergy and Immunology (LJI) are steadily inching closer. Their latest study, published in the current issue of Immunity, demonstrates that optimising the mode and timing of vaccine delivery is crucial to inducing a protective immune response in a preclinical model.
21st June 2017

Chemists develop the ultimate natural sunscreen

Chemists develop the ultimate natural sunscreen
Chemists, materials scientists and nanoengineers at UC San Diego have created what may be the ultimate natural sunscreen. In a paper published in the American Chemical Society journal ACS Central Science, they report the development of nanoparticles that mimic the behavior of natural melanosomes, melanin-producing cell structures that protect our skin, eyes and other tissues from the harmful effects of ultraviolet radiation.
17th May 2017

Protein could increase effectiveness of vaccines

Protein could increase effectiveness of vaccines
Researchers have discovered a protein they believe would help make vaccinations more effective and provide protection from other diseases such as cancer. The findings, which appear online in Scientific Reports, allows for greater understanding of how vaccine enhancers work and can best be used. Researchers from Boston University School of Medicine (BUSM) purified a protein found on the exterior of bacteria (neisseria meningidis) and used it as an accessary to provide a better vaccination response.
7th April 2017


Prophylaxis documents


Sign up to view our publications

Sign up

Sign up to view our downloads

Sign up

SPE Offshore Europe 2017
5th September 2017
United Kingdom Aberdeen Exhibition & Conference Centre
EPE 2017 ECCE Europe
11th September 2017
Poland Warsaw
ON Semiconductor Power Seminars 2017
11th September 2017
United Kingdom
DSEI 2017
12th September 2017
United Kingdom ExCeL, London
RWM 2017
12th September 2017
United Kingdom NEC, Birmingham